North America Anti-Infective Agents Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)    

No. of Pages: 173    |    Report Code: BMIRE00025834    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Anti-Infective Agents Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Anti-Infective Agents Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Anti-Infective Agents Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Targeted Diseases
5.2 Market Opportunities
  • 5.2.1 Rising Government Support for Research Activities
5.3 Future Trends
  • 5.3.1 Development of New Anti-infective Agents
5.4 Impact of Drivers and Restraints

6. North America Anti-Infective Agents Market Regional Analysis

6.1 North America Anti-Infective Agents Market Overview
6.2 North America Anti-Infective Agents Market Revenue 2019-2028 (US$ Million)
6.3 North America Anti-Infective Agents Market Forecast Analysis

7. North America Anti-Infective Agents Market Analysis – by Type

7.1 Anti-Viral
  • 7.1.1 Overview
  • 7.1.2 Anti-Viral: North America Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Anti-Bacterial
  • 7.2.1 Overview
  • 7.2.2 Anti-Bacterial: North America Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Anti-Fungal
  • 7.3.1 Overview
  • 7.3.2 Anti-Fungal: North America Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Anti-Infective Agents Market Analysis – by Range

8.1 Narrow Spectrum and Broad Spectrum
  • 8.1.1 Overview
  • 8.1.2 Narrow Spectrum and Broad Spectrum: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Anti-Infective Agents Market Analysis – by Route of Administration

9.1 IV
  • 9.1.1 Overview
  • 9.1.2 Narrow Spectrum and Broad Spectrum: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Oral
  • 9.2.1 Overview
  • 9.2.2 Narrow Spectrum and Broad Spectrum: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Topical
  • 9.3.1 Overview
  • 9.3.2 Narrow Spectrum and Broad Spectrum: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Anti-Infective Agents Market – North America Analysis

10.1 North America
  • 10.1.1 North America Anti-Infective Agents Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Anti-Infective Agents Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Anti-Infective Agents Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Anti-Infective Agents Market Breakdown, by Range
    • 10.1.1.1.3 US: North America Anti-Infective Agents Market Breakdown, by Route of Administration
  • 10.1.1.2 Canada: North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Anti-Infective Agents Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Anti-Infective Agents Market Breakdown, by Range
    • 10.1.1.2.3 Canada: North America Anti-Infective Agents Market Breakdown, by Route of Administration
  • 10.1.1.3 Mexico : North America Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Anti-Infective Agents Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Anti-Infective Agents Market Breakdown, by Range
    • 10.1.1.3.3 Mexico : North America Anti-Infective Agents Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Anti-Infective Agents Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Allergan Plc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Astellas Pharma Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Bayer AG
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Boehringer Ingelheim International GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Bristol-Myers Squibb Company
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Gilead Sciences, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 GlaxoSmithKline plc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Merck & Co., Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Novartis AG
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Abbott
  2. Allergan Plc.
  3. Astellas Pharma Inc.
  4. Bayer AG
  5. Boehringer Ingelheim International GmbH
  6. Bristol-Myers Squibb Company
  7. F. Hoffmann-La Roche Ltd.
  8. Gilead Sciences, Inc.
  9. GlaxoSmithKline plc.
  10. Merck & Co., Inc.
  11. Novartis AG
north-america-anti-infective-agents-market